Hubei Biocause Heilen Pharmaceutical Co., Ltd. / Financial strength (Piotroski F-Value)
The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.
- Financial strength (Piotroski F-Value)
-
4 / 9
- Return on assets (ROA) greater than 0
- check 2.6%
- Operating cash flow greater than 0
- check $2.09M
- ROA greater than previous year
- close 2.6% ≤ 6.8%
- Cash flow return on assets (CFROA) greater than Return on assets (ROA)
- close 0.7% ≤ 2.6%
- Leverage ratio lower than previous year
- check 0.1% < 0.2%
- Current ratio greater than previous year
- close 1,367.0% ≤ 1,547.0%
- No new common stock issued last year
- check $0.00
- Gross margin greater than previous year
- close 23.5% ≤ 41.8%
- Asset turnover greater than previous year
- close 17.0% ≤ 23.8%
F-Value history
The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.
-
6
-
7
-
4
-
5
-
4
-
5
-
5
-
4
-
6
-
7
-
7
-
8
-
8
-
6
-
5
-
4
-
4